Journal article
Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease
SD Portbury, DJ Hare, C Sgambelloni, K Perronnes, AJ Portbury, DI Finkelstein, PA Adlard
Journal of Alzheimer S Disease | IOS PRESS | Published : 2017
DOI: 10.3233/JAD-170322
Abstract
This study assessed the therapeutic utility of the autophagy enhancing stable disaccharide trehalose in the Tg2576 transgenic mouse model of Alzheimer's disease (AD) via an oral gavage of a 2 trehalose solution for 31 days. Furthermore, as AD is a neurodegenerative condition in which the transition metals, iron, copper, and zinc, are understood to be intricately involved in the cellular cascades leading to the defining pathologies of the disease, we sought to determine any parallel impact of trehalose treatment on metal levels. Trehalose treatment significantly improved performance in the Morris water maze, consistent with enhanced learning and memory. The improvement was not associated with..
View full abstractGrants
Awarded by State Government of Victoria
Funding Acknowledgements
D.J.H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095). DJH is also supported by a National Health and Research Council Industry Career Development Fellowship (GNT1122981) in partnership with Agilent Technologies. In addition, the Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. The Elemental Bio-imaging Facility receives material support from Agilent Technologies.